Thanh bên bài viết

PDF
Ngày xuất bản: 06/07/2022
Số lượt xem tóm tắt: 82
Số lượt xem PDF: 66
DOI: https://doi.org/10.51298/vmj.v515i1.2414
Số xuất bản
Tập 515 Số 1 (2022): Vietnam Medical Journal
Chuyên mục
Các bài báo
Trích dẫn bài báo
Van Phong, H. ., Manh Quan, N. ., Ngoc Dung, N. ., Thi Thu Huyen, N. ., & Tuan Viet, P. . (2022). RESULT OF PLATELETPHERESIS AND ANTI-PLATELET MEDICATION IN TREATMENT OF ESSITIAL THROMBOCYTHEMIA AT VIETNAM - CZECH FRIENDSHIP HOSPITAL IN 2017 - 2019. Tạp Chí Y học Việt Nam, 515(1). https://doi.org/10.51298/vmj.v515i1.2414

RESULT OF PLATELETPHERESIS AND ANTI-PLATELET MEDICATION IN TREATMENT OF ESSITIAL THROMBOCYTHEMIA AT VIETNAM - CZECH FRIENDSHIP HOSPITAL IN 2017 - 2019

Van Phong Hoang 1,, Manh Quan Ngo 2, Ngoc Dung Nguyen 2, Thi Thu Huyen Nguyen 3, Tuan Viet Pham 4
1 Center for Hematology - Blood Transfusion, Vietnam- Czech friendship hospital
2 National Institute of Hematology - Blood Transfusion
3 Internal medical department, Vietnam- Czech friendship hospital
4 Health Strategy and Policy Institute

Nội dung chính của bài viết

Tóm tắt

The study was carried out in 56 essential thrombocytosis patients admitted to Vietnam - Czech hospital in Hai Phong city from 01/01/2017 to 06/2019. Subject: Investigation of the effectiveness of plateletpheresis and anti - platelet medication treatment (combined with hydroxyurea) in essential thrombocytosis. Method: prospective study with clinical intervention. Results: 1. The effectiveness of plateletpheresis. 1.1. Most of patients have improvement regarding symptoms related to microvascular stasis due to thrombocytosis (reduced from 58,3% to 31,8% with p < 0,05). 1.2. After 24 hours of plateletpheresis, platelet count reduced from 1,340 G/l to 736 G/l. 2. The effectiveness of anti-platelet medication after plateletpheresis: after 2 weeks of treatment, most of patients have significant improvements regarding symptoms related to microvascular stasis due to thrombocytosis (reduced from 31,8% to 3,8%).

Chi tiết bài viết

Từ khóa

Essential thrombocytosis, plateletpheresis, anti - platelet medication

Tài liệu tham khảo

1. Binh, V.D., Thanh, N.H., Huong, V.L., Tri, N.A. (2016) A study on essential thrombocythemia at the National Institute for Hematology and Blood Transfusion in 2016. Medical Journal, 446, 826-834.
2. Vietnam Ministry of Health (2016) Essential thrombocythemia, guidance on diagnosis and treatment, 61 - 66.
3. Carobbio, A., Thiele, J., Passanonti, F. (2011) A Risk factors for arterial and venous thrombosis in WHO - defined essential thrombocythemia and international study of 891 patient. Blood, 117, 5,857 - 5,859.
4. Dutcher. JP (2013) Therapeutic Cytapheresis, plasma pheresis and plasma exchange in neoplastic disease of the blood. Springer New York, p 1241 - 1249.
5. Szczeporkowski, Z.M; Winter, J.L; Brandazenko, N., et al. (2010) Guidelines on the use of therapeutic apheresis in clinical fractice - Evidence based approach from the apheresis applications committee of the American Society for Apheresis. Journal of clinical apheresis, 25(3), 83-177.
6. Tefferi, A. and Babri, T. (2015) Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis risk- stratification and management. American Journal of hematology, 90(2), 162-173.